Why Ozempic is so cheap in China

Semaglutide Drug ClassSemaglutide 99 powder, also known as Ozempic in other countries, is the same product. This medication is a member of the GLP-1 receptor agonist medicine class. It reduces blood sugar levels by imitating the effects of glucagon-like peptide-1 (GLP-1). The hormone GLP-1, made in the intestine and rises after eating, can stimulate insulin release and prevent glucagon release, lowering blood sugar levels. It can imitate GLP-1’s effects and aid in blood sugar regulation because it buy semaglutide online no prescription is a GLP-1 receptor agonist.

How should FDA and Congress address the lack of reference standard?

While some experts praise the policy to keep medicines affordable, drugmakers worry that slashed prices could hinder research and development costs. However, “the sheer size of China’s healthcare market” — the world’s second-largest — means that companies can recoup their research costs, one pharma marketing executive told Insider. This, in turn, created a legal pathway for pharmacy compounding of exact copies of the patent-protected, FDA-approved products. These compounded products are not made in drug manufacturing facilities but are mixed by pharmacies. Telehealth services offer several weight loss medications, including Wegovy.

Novo Nordisk braces for generic challenge to Ozempic, Wegovy in China

If you will be using semaglutide at home, your doctor will teach you how the injections will be given. Using this medicine with any of the following medicines is usually not recommended, but may be required in some cases. It is important for patients to wait for regulatory approval and availability through legitimate channels to ensure they receive a safe and effective treatment. The FDA has approved cemiplimab-rwlc (Libtayo®) for adjuvant treatment of adults with high-risk cutaneous squamous cell carcinoma after surgery and radiation. Libtayo is already approved for advanced CSCC, basal cell carcinoma, and NSCLC. Supported by robust technical expertise, Sinoway offers semaglutide produced through both recombinant protease (biological method, similar to the original) and peptide synthesis methods.

An affiliated provider will then receive this form for review to determine if Wegovy is suitable for the person concerned. Goldman Sachs analysts estimated in an August report that generics could lead to a price reduction of around 25% for semaglutide in China. The weekly Ozempic injection costs around $100 for each 3mL dose through China’s public hospital network, Clarivate’s Verma said. The number of adults who are overweight or obese in China is projected to reach 540 million and 150 million, respectively, in 2030, up 2.8 and 7.5 times from 2000 levels, according to a 2020 study by Chinese public health researchers. Of course, nobody believed her, and we thought she went and had weight loss surgery. She started complaining about how many pharmacies she went to to try and get her prescriptions re-filled with to no avail.

In fact, there is a global shortage affecting even those with prescriptions. Meanwhile, TikTok and Instagram are flooded with people sharing their semaglutide weight-loss journeys. Some social media posters explain the disparity by saying that they are taking “generic” semaglutide. But semaglutide (like similar drugs such as liraglutide and tirzepatide) is still under patent, meaning it is illegal to make a generic form. A few years ago, celebrity weight-control practices were out of most people’s reach. Live-in chefs and personal trainers, not to mention elaborate surgical procedures like the Brazilian butt lift, were not real options for most.

We also provide key intermediates for research and development purposes without infringing on existing patents. So in China, Ozempic jabs cost 478 Chinese yuan, or $67, per China’s National Reimbursement Drugs List (NRDL). That price stands in stark contrast to the US, where an Ozempic injection costs $995, per the pharmaceutical website Drugs.com. It can help you save money on Wegovy and give you access to weight loss support resources.

While the Denmark-based company expects the drug’s weight-loss counterpart Wegovy to be approved in China later this year, competitors are springing up to get in on the GLP-1 cash cow. While it is therefore unclear as to how the Chinese market will play out, given the lack of precedent, patent losses with blockbuster drugs in other disease areas offer a clue. Generics and biosimilars can be on average 80% cheaper, meaning patients often switch away from the more expensive branded alternative.

Remarkably, Jiuyuan Gene’s marketing application could lead to China’s initial biosimilar approval. This competitive environment not only addresses the growing obesity epidemic but also aims to provide affordable alternatives, as illustrated by Wegovy’s recent market introduction at approximately $193.27 per month. The healthcare regulations governing biosimilars in China are rapidly changing, particularly with the anticipated release of semaglutide biosimilars. As the patent for Novo Nordisk’s Ozempic nears expiration in 2026, establishing a complete regulatory framework is critical. The National Medical Products Administration (NMPA) oversees the approval process, ensuring that biosimilars demonstrate equivalent efficacy and safety to their reference products. I first explain the complexity of peptides and lay out the regulatory framework for manufacturing quality in API and bulk products.

Can I get a prescription for Wegovy online?

By targeting multiple aspects of metabolism, it helps patients achieve better blood sugar control, significant weight loss, and improved overall health outcomes. As with any prescription medication, professional guidance is essential to ensure safe and effective use. Semaglutide powder is often used in adults with type 2 diabetes with an exercise program and a healthy diet to control blood sugar levels. It is important to note that semaglutide should never be used to treat type 1 diabetes. This is a condition in which the body cannot produce insulin and, therefore, cannot regulate sugar in the blood.

The data, including for Novo Nordisk’s Ozempic shipments, only goes back to March 2023, so I do not observe the initial semaglutide import activity. Table 1 summarizes the regulatory standards for semaglutide bulk used in compounding versus semaglutide API used in abbreviated new drug applications (ANDAs). I am using ANDAs as a reference because they are copies of the branded semaglutide products, just as compounded products are.

The lower prices come at the expense of the drugmakers forced to swallow hefty price cuts

Zuo Ya-Jun, general manager of weight loss drugmaker Shanghai Benemae Pharmaceutical, said a product being competitive would depend on distinguishing features such as efficacy, durability of the treatment and a company’s sales abilities. Novo also faces competition from internationally well-known firms, including Eli Lilly, whose diabetes drug Mounjaro received approval from China in May. HSBC analysts expect China’s approval this year or in the first half of 2025 for Lilly’s weight loss drug with the same active ingredient. At least 11 semaglutide drug candidates from Chinese firms are in the final stages of clinical trials, according to records in a clinical trial database reviewed by Reuters. Chinese consumers wanting a quick weight loss fix are turning to a diabetes drug, raising concerns over the misuse and potential side effects from unsupervised prescriptions.

A glucagon hormone encourages the liver’s glycogen stores to break down, boosting blood sugar levels. By inhibiting glucagon release, peptides further aid blood sugar control.Slowing gastric emptying and decreasing stomach motility can also change how the gastrointestinal system works when it binds to GLP-1 receptors. That means food stays in the stomach longer, allowing it to be gradually digested and absorbed, hindering the rise in blood sugar.

Less than a quarter of Chinese facilities marketing semaglutide bulk have been inspected since they began marketing the product. But this low number is not due to the lack of FDA effort—FDA has inspected five of the first seven semaglutide bulk NDCs in this sample but simply cannot catch up with the onslaught of new NDC filers. Complicating FDA’s efforts is the fact that close to 60% of facilities with NDC codes are new to FDA—and were not registered with FDA before the onset of semaglutide shortage. The ascertainable semaglutide volume that was imported into the U.S. during those 18 months is significant. The median shipment size was 51g, which might seem small, but 1g is equivalent to 4,000 starting doses of semaglutide. These six shipments accounted for 221kg out of the 268kg reported metric volume during the March 2023 to September 2024 timeframe.

• Jennie Smith, a seamstress at a ballet school in Kent, Ohio, had been trying to lose weight and keep it off for years.
• Check with your doctor right away if you have sudden and severe stomach pain, chills, constipation, nausea, vomiting, fever, or lightheadedness.
• About semaglutide Semaglutide is a GLP-1 receptor agonist developed by Novo Nordisk (Novo Nordisk).
• The oral version of semaglutide was approved for listing by the National Medical Products Administration in January 2024 for the treatment of type 2 diabetes, and achieved sales of 511 million Danish kroner (US$74 million) in 2024.
• Based on these, customers have given much good feedback to our products.

AI Data Centers Are an Even Bigger Disaster Than Previously Thought

It has a place with a class of medications called glucagon-like peptide-1 receptor agonists (GLP-1 RAs). It works by increasing the release of insulin.It is really great for bringing down glucose levels. In addition to controlling blood sugar, sommarlutide may also promote weight loss. For the indication of weight loss, no domestic semaglutide has been reported for production, but there are products under development that have entered Phase III clinical trials. The weight management indication of semaglutide applied for by Federal Biotech (Zhuhai Hengqin), a wholly-owned subsidiary of Federal Pharmaceutical, was approved for clinical trials in April 2023.

However, low blood sugar can occur when you use semaglutide with other medicines, including insulin or sulfonylureas, that can lower blood sugar. Low blood sugar also can occur if you delay or miss a meal or snack, exercise more than usual, drink alcohol, or cannot eat because of nausea or vomiting. As Reuters reports, Chinese drug manufacturers are working on creating at least 15 generic versions of the glucagon-like peptide-1 (GLP-1) agonist drugs as Ozempic maker Novo Nordisk makes money hand over fist in the region.